Last reviewed · How we verify
FSME-immune
FSME-immune is a vaccine designed to prevent tick-borne encephalitis.
FSME-immune is a vaccine designed to prevent tick-borne encephalitis. Used for Prevention of tick-borne encephalitis.
At a glance
| Generic name | FSME-immune |
|---|---|
| Sponsor | Sormland County Council, Sweden |
| Modality | Biologic |
| Therapeutic area | Infectious Diseases |
| Phase | Phase 2 |
Mechanism of action
The vaccine works by stimulating the body's immune system to produce antibodies against the tick-borne encephalitis virus, providing long-term protection against the disease.
Approved indications
- Prevention of tick-borne encephalitis
Common side effects
- Injection site reactions
- Fatigue
- Headache
Key clinical trials
- Primary TBE Vaccination for the Elderly (PHASE4)
- New Study - Humoral Response to Tick-borne Encephalitis Vaccine in Elderly (PHASE2, PHASE3)
- Comparison of Vaccination Routes: Subcutaneous Versus Intramuscular Application of FSME-Immun® (PHASE4)
- Humoral Response to Tick-borne Encephalitis Vaccine in Elderly (PHASE2, PHASE3)
- Influence of Persistent CMV-infection on Immune Senescence (PHASE4)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |